RecruitingNCT01761981

Institutional Registry of Haemorrhagic Hereditary Telangiectasia


Sponsor

Hospital Italiano de Buenos Aires

Enrollment

590 participants

Start Date

Jan 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to create an institutional and population-based registry of Haemorrhagic Hereditary Telangiectasia with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival. This study will also describe the occurrence of Haemorrhagic Hereditary Telangiectasia in the population of HIBA in the Central Hospital, as well as the characteristics of clinical presentation and evolution.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with haemorrhagic hereditary telangiectasia. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hospital Italiano de Buenos Aires

Buenos Aires, Buenos Aires, Argentina

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01761981